ANALISIS FAKTOR-FAKTOR TERJADINYA MEDICATION ERROR DI APOTEK RSI IBNU SINA BUKITTINGGI

نویسندگان

چکیده

A medication error is a health problem that has many impacts on patients ranging from mild risk to even the most severe of causing death. The number mistakes in prescription writing at Ibnu Sina Bukittinggi Hospital September 2016 increased 60.90%. Therefore, study aims analyze factors pharmacy RSI. This type research uses qualitative approach. Informants this were 5 people who taken intentionally (purposive sampling). results showed prescribing occurred unclear so it could lead errors administration drug doses. Errors dispensing phase occur time preparation delivery by pharmacists, which wrong way taking drugs storage rack due packaging or similar names. Dispensing also incorrect identification and do not cross check again. process using pharmacists. It can be concluded RSI error, error.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Tissue-Faktor im akuten Koronarsyndrom

Zusammenfassung Die Ruptur einer arteriosklerotischen Plaque mit nachfolgender Thrombusbildung und Gewebsischämie stellt das führende pathophysiologische Korrelat des akuten Koronarsyndroms dar. Gewebsthromboplastin oder Tissue-Faktor (TF) als wichtigster physiologischer Initiator der extrinsischen Gerinnungskaskade nimmt eine zentrale Rolle in der Pathogenese des akuten Koronarsyndroms ein. Da...

متن کامل

Klinisch relevante Blutungsneigung infolge eines erworbenen Faktor XIII-Mangels

Background: Acquired factor XIII (FXIII) deficiency is associated with reduced clot firmness and increased bleeding in patients undergoing major surgery. In contrast, only limited information is available on the haemo static relevance of acquired FXIII deficiency in non-surgical patients. Case report: An 81-year-old patient, who had experienced acute type-A dissection of the aorta eight years e...

متن کامل

Erfolgreiche Langzeit-Behandlung mit Mycophenolat-mofetil bei einem Kind mit erworbenem Faktor-VIII-Inhibitor

Here, we report about a boy (age: 18 years) who developed an acquired factor VIII inhibitor at the age of 9 years. He presented with bleeding in his right ankle, multiple haematomas and a high-titer factor VIII type II inhibitor (400 BU). Therapy: He received treatment with MMF (CellCept®), dexamethasoneimmunoglobulin pulses, and rituximab together with high dose FVIII (Hannover protocol). His ...

متن کامل

Das Problem neuer Faktor-VIII-Missense-Mutationen fÃ1⁄4r die genetische Beratung der Hämophilie A

The problem of novel FVIII missense mutations for haemophilia A genetic counseling R. Schneppenheim1; J. Schröder2; T. Obser1; F. Oyen1; S. Schneppenheim3; J. Oldenburg2 1Department of Paediatric Haematology & Oncology, University Medical Center Hamburg-Eppendorf, Germany; 2Institute of Experimental Haematology and Transfusion Medicine, University Clinic Bonn, Germany; 3Coagulation Laboratory A...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Jurnal endurance

سال: 2022

ISSN: ['2477-6521']

DOI: https://doi.org/10.22216/jen.v6i1.133